RPG Life Sciences Ltd

Stage 2 · Advancing · week 15Setup 8.0 ★★★ PrimeStrong +13.2

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. More about the company

₹2,892.8
-1.38% today
₹4,784 Cr · Small cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
-6.4%
₹1,744 lo₹3,089.2 hi
6.4% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 15
1w13w26w
Week 15 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
23.7%
200 DMA: ₹2,338.2 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.62x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↑ ⇈
Accelerating · MA20 +6.7% vs MA50 +2.2% / 10d
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+6.3%
3M
+18.0%
6M
+52.2%
YTD
+22.9%
1Y
+28.9%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
This stock ranks #40 of 77 Stage 2 stocks in Health Care by RS.
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Ranks #34 of 61 Stage 2 stocks in this industry.
Stage Cycle Timeline2023-07-12 → 2026-10-07
S2 41w
S2 22w
S4 16w
S2 15w
2023-07-122026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 41w → S3 10w → S2 22w → S3 10w → S2 4w → S3 2w → S2 3w → S4 8w → S1 4w → S2 9w → S3 7w → S2 3w → S3 7w → S4 16w → S1 7w → S2 15w current
Total tracked: 169 weeks across 16 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-07
Pullback Hunter
Latest: 2026-08-21
60 appearances in last 60 days. First seen: 2026-07-10.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S2
Wk 15 · Vol 0.62x
2026-10-06S2
Wk 15 · Vol 0.56x
2026-10-05S2
Wk 15 · Vol 0.91x
2026-10-01S2
Wk 15 · Vol 1.43x
2026-09-30S2
Wk 15 · Vol 1.86x
2026-09-29S2
Wk 14 · Vol 3.77x
2026-09-28S2
Wk 14 · Vol 1.85x
2026-09-25S2
Wk 14 · Vol 4.77x
2026-09-24S2
Wk 14 · Vol 2.50x
2026-09-23S2
Wk 14 · Vol 6.39x
2026-09-22S2
Wk 13 · Vol 0.32x
2026-09-21S2
Wk 13 · Vol 0.17x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹2,757.5
200 DMA
₹2,338.2
52W High
₹3,089.2
52W Low
₹1,744
5D Low
₹2,892.8
Resistance levels (recent highs)
20d High
₹3,089.2
60d High
₹3,089.2
120d High
₹3,089.2
250d High
₹3,089.2
Next resistance
+6.8%
to 20d High
Ask the Market AI about RPGLIFEAsk →
P/E (TTM)
18.2
Forward 78.1
Earnings Growth (YoY)
-74.5%
Revenue +23.6%
ROE
+20.3%
Profit margin +16.3%
Dividend Yield
0.90%
P/B 6.1
About this companyHealth Care· Pharmaceuticals

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. It also provides generics for immunosuppressant therapy; and finished dosage formulations for various therapies, which include nephrology, rheumatology, oncology, gastroenterology, cardiology, orthopedics, nutritional, diabetology, respiratory, neuropsychiatry, urology, vitamins and minerals, gastrointestinal, pain management, anti-diabetic, gynecology and pediatrics, cardiovascular, pediatrics, neurology, anti-dengue, dermatology, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.